Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Operating Expenses | 9,891 | 12,402 | 8,755 | 7,038 | 4,194 |
| Operating Income | -9,891 | -12,402 | -8,755 | -7,038 | -4,194 |
| Interest Expense | 446 | 9 | 8 | 430 | 566 |
| Other Income | 2,285 | 1,629 | -34 | 32 | 200 |
| Pre-tax Income | -8,052 | -10,782 | -8,797 | -7,435 | -4,560 |
| Net Income Continuous | -8,052 | -10,782 | -8,797 | -7,435 | -4,560 |
| Net Income | $-8,052 | $-10,782 | $-8,797 | $-7,435 | $-4,560 |
| EPS Basic Total Ops | -52,642.64 | -115,915.90 | -0.23 | -0.31 | -0.36 |
| EPS Basic Continuous Ops | -52,650.28 | -115,845.70 | -0.21 | -0.31 | -0.36 |
| EPS Diluted Total Ops | -52,642.64 | -115,915.90 | -0.23 | -0.31 | -0.36 |
| EPS Diluted Continuous Ops | -52,650.28 | -115,845.70 | -0.21 | -0.31 | -0.36 |
| EBITDA(a) | $-9,524 | $-11,977 | $-8,258 | $-6,453 | $-3,614 |